Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation

Transplantation

Volumn 69, Issue 5, 2000, Pages 847-853

  Julius, Barbara K ^a,b   Attenhofer Jost, Christine H ^a   Sütsch, Gabor ^a   Brunner, Hans Peter ^a,c   Kuenzli, Andreas ^a   Vogt, Paul R ^a   Turina, Marko ^a   Hess, Otto M ^a,d   Kiowski, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; FEMALE; FOLLOW UP; HEART FUNCTION; HEART TRANSPLANTATION; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; MALE; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0342635455     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00030     Document Type: Article

References (48)

1. Weis M, von SW. Cardiac allograft vasculopathy: a review. Circulation 1997; 96: 2069.
2. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 1998; 17: 744.
3. Yeung AC, Davis SF, Hauptman PJ, et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant 1995; 14: S215.
4. Gao SZ, Alderman EL, Schroeder JS, et al. Progressive coronary luminal narrowing after cardiac transplantation. Circulation 1990; 82: IV269.
5. Rickenbacher PR, Pinto FJ, Chenzbraun A, et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995; 25: 171.
6. Caracciolo EA, Wolford TL, Underwood RD, et al. Influence of intimai thickening on coronary blood flow responses in orthotopic heart transplant recipients. A combined intravascular Doppler and ultrasound imaging study. Circulation 1995; 92: II 182.
7. Fish RD, Nabel EG, Selwyn AP, et al. Responses of coronary arteries of cardiac transplant patients to acetylcholine. J Clin Invest 1988; 81: 21.
8. Anderson TJ, Meredith IT, Uehata A, et al. Functional significance of intimai thickening as detected by intravascular ultrasound early and late after cardiac transplantation. Circulation 1993; 88: 1093.
9. Davis SF, Yeung AC, Meredith IT, et al. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation 1996; 93: 457.
10. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
11. Buchi M, Hess OM, Kirkeeide RL, et al. Validation of a new automatic system for biplane quantitative coronary arteriography. Int J Card Imag 1990; 5: 93.
12. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990;15: 459.
13. Gould KL. Coronary artery stenosis. New York: Elsevier, 1990; 93.
14. Suter TM, Buechi M, Hess OM, et al. Normalization of coronary vasomotion after percutaneous transluminal coronary angioplasty? Circulation 1992; 85: 86.
15. Chenzbraun A, Pinto FJ, Alderman EL, et al. Distribution and morphologic features of coronary artery disease in cardiac allografts: an intracoronary ultrasound study. J Am Soc Echocardiogr 1995; 8: 1.
16. Velican D, Velican C. Comparative study on age-related changes and atherosclerotic involvement of the coronary arteries of male and female subjects up to 40 years of age. Atherosclerosis 1981; 38: 39.
17. Bieber CP, Hunt SA, Schwinn DA, et al. Complications in long-term survivors of cardiac transplantation. Transplant Proc 1981; 13: 207.
18. Keogh Am, Valantine HA, Hunt SA, et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant 1992: 11: 892.
19. Jamieson SW, Oyer E, Baldwin J. et al. Heart transplantation in end-stage ischemic heart disease: the Stanford experience. J Heart Transplant 1984; 3: 224.
20. Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of eyclosporine and azathioprine regimens. Circulation 1989; 80: III 100.
21. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with eyclosporine and prednisone. Circulation 1987; 76: 827.
22. Tuzcu EM, Hobbs RE, Rincon G, et al. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation 1995; 91: 1706.
23. Botas J, Pinto FJ, Chenzbraun A, et al. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation 1995; 92: 1126,
24. Veinot JP, Davies RA, Masters RG, Walley VM. Angiographic underestimation of coronary artery disease in a cardiac transplant donor. Canad J Cardiol 1995; 11: 1039.
25. Gao HZ, Hunt SA, Alderman EL, et al. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol 1997; 29: 623.
26. Barbir M, Banner N, Thompson GR, et al. Relationship of immunosuppression and serum lipids to the development of coronary arterial disease in the transplanted heart. Int J Cardiol 1991; 32: 51.
27. Ratkovec RM, Wray RB, Renlund DG, et al. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation. J Thorac Cardiovasc Surg 1990; 100: 6.
28. Petrossian GA, Nichols AB, Marboe CC, et al. Relation between survival and development of coronary artery disease and anti-HLA antibodies after cardiac transplantation. Circulation 1989; 80: III 122.
29. Herskowitz A, Tamura F, Ueda K, et al. Induction of donor major histocompatibility complex antigens in coronary arterial vessels: mechanism of arterial vasculitis in rat allografts treated with cyclosporine. J Heart Transplant 1989; 8: 11.
30. Hammond EH, Yowell RL, Price GD, et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant 1992; 11: S111.
31. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488.
32. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491.
33. Gage JE, Hess OM, Murakami T, et al. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 1986; 73: 865.
34. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 1989; 79: 1043.
35. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992; 85: 1927.
36. Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993; 88: 2139.
37. Zeiher AM, Schachlinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 1994; 89: 2525.
38. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314.
39. Vassalli G, Gallino A, Kiowski W, et al. Reduced coronary flow reserve during exercise in cardiac transplant recipients. Circulation 1997; 95: 607.
40. Pinto FJ, St GF, Fischell TA, et al. Nitroglycerin-induced coronary vasodilation in cardiac transplant recipients. Evaluation with in vivo intracoronary ultrasound. Circulation 1992; 85: 69.
41. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373.
42. Hollenberg SM, Tamburro P, Klein LW, et al. Discordant epicardial and microvascular endothelial responses in heart transplant recipients early after transplantation. J Heart Lung Transplant 1998; 17: 487.
43. Heroux AL, Silverman P, Costanzo MR, et al. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy. Circulation 1994; 89: 272.
44. Nishimura RA, Lerman A, Chesebro JH, et al. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound [published erratum appears in J Am Coll Cardiol 1995; 26 (6): 1564]. J Am Coll Cardiol 1995; 26: 41.
45. Bracht C, Yan XW, Brunnner HP, Suetsch G, Kiowski W. Cyclosporine A and control of vascular tone in the human forearm: influence of post-transplant hypertension. J Hypertens 1999; 17: 357.
46. Khalil A, Carrier M, Latour JG, Pelletier LC. Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms. Circulation 1996; 94: II 308.
47. Lo RA, Passaquin AC, Andre P, Skutella M, Ruegg UT. Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol 1996; 118: 885.
48. Dzau VJ. Local contractile and growth modulators in the myocardium. Clin Cardiol 1993; 16: II 5.